In development: Indicators
Showing 1 to 10 of 11
| Title | Type | Expected publication date |
|---|---|---|
| Diabetes: metformin and SGLT2 inhibitors (T2DM) | TBC | |
| Diabetes: metformin, SGLT2 inhibitors and semaglutide (T2DM and CVD) | TBC | |
| Diabetes: metformin and SGLT2 inhibitors (early onset T2DM) | TBC | |
| Pain: Strong opioid use (osteoarthritis and chronic low back pain) | TBC | |
| Pain: Strong opioid use (MSK) | TBC | |
| Pain: Annual review long term opioid use | TBC | |
| Acne: long term antibiotic use | TBC | |
| Acne: lymecycline combination therapy | TBC | |
| Infections: delayed antibiotic prescribing | TBC | |
| Weight management: annual nutritional monitoring post bariatric surgery | General practice indicators suitable for use in QOF | TBC |